Concepedia

Publication | Closed Access

Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition

42

Citations

42

References

2010

Year

Abstract

The effects of subconjunctival injection of bevacizumab in treating corneal NV associated with lipid deposition were significant in some patients.

References

YearCitations

Page 1